Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Pfizer has expanded its research on vaccines to eventually safeguard people from cradle to grave, from shots for pregnant women to protect their babies from the moment of birth to vaccines for senior citizens with waning immune systems
read more
Amgen on Tuesday received European approval for its first-of-a-kind cholesterol drug that lowers levels of the artery-clogging substance more than older drugs that have been prescribed for decades.
read more
PAREXEL International Corporation has launched the next generation of its Perceptive MyTrials® platform with advanced analytics capabilities.
read more
Bristol-Myers said Tuesday that federal regulators will help speed up development for one of its experimental HIV drugs.
read more
Cytovance Biologics, Inc. announces that it has teamed up with NeuroFx to develop and manufacture stem cell derived, cell-free therapy for neurological conditions.
read more
Analysts say they expect more tie-ups are coming in the generic drug industry in the wake of Teva's mammoth deal for the generic drug business of Allergan.
read more
Novartis has announced a swap of clinical assets for equity with Mereo BioPharma Group Ltd.
read more
CVS Health Corp. deliberately overcharged some pharmacy customers for generic drugs by submitting claims to their insurance companies at inflated prices, according to a lawsuit filed Thursday in federal court in San Francisco.
read more
The Food and Drug Administration said Thursday that some doctors and pharmacies are getting confused by the similar names of an antidepressant and a blood-thinning medicine.
read more
Xcelience, a contract development and manufacturing organization (CDMO), announced today that it has made a structured cash investment in Powdersize, a Pennsylvania-based company specializing in milling, micronization and powder size classification ...
read more
Catalent Pharma Solutions welcomed the announcement by OPKO Health that the FDA has accepted for review OPKO’s New Drug Application for a new treatment for chronic kidney disease (CKD) and vitamin D insufficiency, which uses Catalent’s proprietary ...
read more
Pharma Tech Industries, a pharmaceutical contract manufacturer and packager of powder products, has promoted Matthew Milner, who has risen through the ranks in supply chain operations at the company since 2008, to Director of Supply Chain Operations.
read more
Wednesday, August 05, 2015
AstraZeneca has announced that MedImmune, its global biologics research and development arm, has entered into an exclusive clinical trial collaboration with Mirati Therapeutics, Inc., an oncology company focusing on genetic and epigenetic drivers of ...
read more
Wednesday, August 05, 2015
Catalent, a global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has formed an advisory board to strategically shape growth of the company’s biologics business.
read more
Wednesday, August 05, 2015
Shire is offering to buy Baxalta for about $30 billion in stock as it attempts to solidify its strengthening position in rare disease treatments.
read more